Your AI-Trained Oncology Knowledge Connection!
Video
Author(s):
A review of other ongoing trials and emerging treatment regimens in the space and a summary of takeaways from trials on other squamous cell cancers that may also be applied to ESCC.
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
May 9th 2025 - Jun 14th 2025
May 8th 2025 - May 9th 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
May 9th 2025 - Jun 14th 2025
May 8th 2025 - May 9th 2026
May 2nd 2025 - Jun 7th 2025
May 1st 2025 - Jun 6th 2025
May 1st 2025 - May 2nd 2026
Breast Cancer Experts Bookmark Top Abstracts to Watch at the 2025 ASCO Annual Meeting
Poll Results Punctuate Key Lung Cancer Abstracts Driving Intrigue Ahead of ASCO 2025
Insights From Liso-cel Combined With Ibr for R/RCLL/SLL: Primary Results From the Open-Label, Phase 1/2 Transcend CLL 004 Study
Overview of the Fixed-Duration Epcoritamab + R-Mini-CHOP in Patients With Previously Untreated DLBCL Ineligible for Full-Dose R-CHOP: Updated Results from Arm 8 of the Epcore NHL-2 Trial
2 Commerce Drive
Cranbury, NJ 08512